Market Samachar
CNBC
·
GLOBAL
·
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals - CNBC
As reported by CNBC
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on CNBC ↗
Market Samachar is a news aggregator. This article was originally published by
CNBC. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
More from Market Samachar